112
Participants
Start Date
February 1, 2021
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2025
Nabilone
After the screening period, participants randomized to the nabilone arm will receive nabilone for 8 weeks. Participants will then be followed for 8 weeks following completion of the study treatment.
Placebo
After the screening period, participants randomized to the placebo arm will receive placebo capsules for 8 weeks. Participants will then be followed for 8 weeks following completion of the study treatment.
RECRUITING
University of Calgary, Calgary
RECRUITING
London Health Sciences Centre, London
RECRUITING
Sunnybrook Health Sciences Centre, Toronto
RECRUITING
Centre for Addiction and Mental Health, Toronto
RECRUITING
St. Michael's Hospital, Toronto
RECRUITING
Ontario Shores Centre for Mental Health Sciences, Whitby
Alzheimer's Drug Discovery Foundation
OTHER
Sunnybrook Health Sciences Centre
OTHER